Les résultats et les conclusions des travaux menés par l’écosystème Experts Recherche Lymphome sont publiés dans des journaux médicaux de premier plan.
Calym 2017_RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.
Calym 2019_Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner.
Calym 2017_Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.
Calym 2018_SAMHD1 acts at stalled replication forks to prevent induction of interferon.
Calym 2019_EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation.
2019_CSF1R and BTK inhibitions as novel strategies to disrupt the dialogue between mantle cell lymphoma and macrophages
Calym 2018_Whole Exon Sequencing of Human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.
Calym 2018_p53 regulates CD46 expression and Measles virus infection in myeloma cells.
Lysa 2018_BH3 mimetic toolkit guides the respective use of BCL2 and MCL1 BH3 mimetics in myeloma treatment.
Calym 2016_Microenvironment-dependent proliferation and mitochondrial priming loss in mantle cell lymphoma is overcome by anti-CD20.
Lysa 2020_LYSA_Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Lysa 2019_LYSA_PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.